Quanterix Corp is a biotechnology company that specializes in developing and commercializing ultra-sensitive digital immunoassay technology aimed at advancing precision health and diagnostics

By harnessing its innovative platform, Quanterix enables the detection of biomarkers at extremely low levels, facilitating early disease detection, monitoring therapeutic responses, and ultimately enhancing patient care. Their solutions are utilized across various fields, including neurology, oncology, and infectious diseases, driving progress in research and clinical applications to improve health outcomes.